These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23427817)

  • 21. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
    Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
    Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
    Koo T; Popplewell L; Athanasopoulos T; Dickson G
    Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
    Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
    Front Immunol; 2021; 12():674242. PubMed ID: 33995418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
    Goehringer C; Rutschow D; Bauer R; Schinkel S; Weichenhan D; Bekeredjian R; Straub V; Kleinschmidt JA; Katus HA; Müller OJ
    Cardiovasc Res; 2009 Jun; 82(3):404-10. PubMed ID: 19218289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.
    Fougerousse F; Bartoli M; Poupiot J; Arandel L; Durand M; Guerchet N; Gicquel E; Danos O; Richard I
    Mol Ther; 2007 Jan; 15(1):53-61. PubMed ID: 17164775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy.
    Wang Z; Allen JM; Riddell SR; Gregorevic P; Storb R; Tapscott SJ; Chamberlain JS; Kuhr CS
    Hum Gene Ther; 2007 Jan; 18(1):18-26. PubMed ID: 17176210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D.
    Mendell JR; Rodino-Klapac LR; Rosales XQ; Coley BD; Galloway G; Lewis S; Malik V; Shilling C; Byrne BJ; Conlon T; Campbell KJ; Bremer WG; Taylor LE; Flanigan KM; Gastier-Foster JM; Astbury C; Kota J; Sahenk Z; Walker CM; Clark KR
    Ann Neurol; 2010 Nov; 68(5):629-38. PubMed ID: 21031578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific humoral tolerance or immune augmentation induced by intramuscular delivery of adeno-associated viruses encoding CTLA4-Ig-antigen fusion molecules.
    Logan GJ; Wang L; Zheng M; Ginn SL; Coppel RL; Alexander IE
    Gene Ther; 2009 Feb; 16(2):200-10. PubMed ID: 19037242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance.
    Hayashita-Kinoh H; Yugeta N; Okada H; Nitahara-Kasahara Y; Chiyo T; Okada T; Takeda S
    Mol Ther; 2015 Apr; 23(4):627-37. PubMed ID: 25586688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.
    Hardet R; Chevalier B; Dupaty L; Naïmi Y; Riou G; Drouot L; Jean L; Salvetti A; Boyer O; Adriouch S
    Mol Ther; 2016 Feb; 24(1):87-95. PubMed ID: 26265250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
    Chikhlikar P; Barros de Arruda L; Agrawal S; Byrne B; Guggino W; August JT; Marques ET
    Virology; 2004 Jun; 323(2):220-32. PubMed ID: 15193918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle.
    Clark KR; Sferra TJ; Johnson PR
    Hum Gene Ther; 1997 Apr; 8(6):659-69. PubMed ID: 9113506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CpG-depleted adeno-associated virus vectors evade immune detection.
    Faust SM; Bell P; Cutler BJ; Ashley SN; Zhu Y; Rabinowitz JE; Wilson JM
    J Clin Invest; 2013 Jul; 123(7):2994-3001. PubMed ID: 23778142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer.
    Moulay G; Masurier C; Bigey P; Scherman D; Kichler A
    Gene Ther; 2010 Nov; 17(11):1400-10. PubMed ID: 20596058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
    Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
    Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
    Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
    Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
    Lu Y; Song S
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.